Who was studied?
36 female C57BL/6N mice bearing bilateral MC38 tumors.
What does the publication report?
PRaG reduced intratumoral granulocytic suppressor cells and enhanced effector function in draining nodes. Depletion of CD8+ T cells, but not CD4+ T cells, weakened tumor control.
Safety findings
Animal research does not establish human safety.
How should we interpret it?
A mechanistic conference abstract from the same MC38 research program as the Chinese preprint; not independent human efficacy evidence.
Read the original source
This independently written summary was checked against the publicly available abstract. Selected figures, where included, are checked against the full publication. This is not a full-paper translation or a clinical recommendation.
Mechanistic Study of the Anti-Tumor Effects of PRaG Therapy in a Mouse Colorectal Cancer Tumor Model · DOI: 10.1016/j.ijrobp.2024.07.809
Related publications from the same research program
Educational reporting, not individualized medical advice. Discuss treatment decisions with your clinical team.